KK

Komal Kalla

Active Director Director DIN 05267334
DIN 05267334 First appointment Apr 2012 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Apr 2012
Shareholding value β€’β€’β€’β€’ Premium profile

About Komal Kalla

Data last updated:

Komal Kalla is a Director at S R Kalla Hospital Private Limited (since 2012) and Director at Friends Ct Scan Centre Private Limited (since 2012). The companies operate in Healthcare.

DIN 05267334
Primary Designation Director
Industry Healthcare
First Appointment 02 Apr 2012
Oldest Company Age 20 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
S R Kalla Hospital Private Limited U85110RJ2010PTC033144
Director04 Apr 20122010Active
Director02 Apr 20122006Active

Board colleagues of Komal Kalla

Directorship timeline

Open interactive timeline →
Friends Ct Scan Centre Private Limited
S R Kalla Hospital Private Limited
Premium access

Shareholding and investment profile for Komal Kalla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Komal Kalla

Komal Kalla currently holds 2 directorships: S R Kalla Hospital Private Limited (Director, since 04 Apr 2012); Friends Ct Scan Centre Private Limited (Director, since 02 Apr 2012).

Komal Kalla was first appointed on 02 Apr 2012 as Director at Friends Ct Scan Centre Private Limited.

The current boards of Komal Kalla's companies include Mukesh Kalla (S R Kalla Hospital Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available